CLVR (Clever Leaves Holdings) Research & Development: $1.14 Mil (TTM As of Dec. 2023)


CLVR Clever Leaves Holdings Inc CLVR
12 GF Score
Price $0.00
View Full Analysis

What is Clever Leaves Holdings Research & Development?

Clever Leaves Holdings CLVR -99.50% 12 Research & Development is $1.14 Mil as of Dec. 2023. GuruFocus rates CLVR with a GF Score™ of 12/100.

Research & Development is the aggregate amount of research and development expenses during the year. Clever Leaves Holdings's Research & Development for the three months ended in Dec. 2023 was $0.23 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was $1.14 Mil.

Clever Leaves Holdings  (OTCPK:CLVR) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Clever Leaves Holdings Research & Development Related Terms

Clever Leaves Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for Clever Leaves Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clever Leaves Holdings Research & Development Chart

Clever Leaves Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
0.00 1.01 1.55 1.72 1.14

Clever Leaves Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.61 0.21 0.40 0.29 0.23
CLVR
12GF Score
Clever Leaves Holdings Inc CLVR
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clever Leaves Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.14 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $1.14 Mil mean?
Clever Leaves Holdings (CLVR) has a Research & Development of $1.14 Mil as of Dec. 2023. Research and development expense is the total cost for research and development activities. View historical data on Clever Leaves Holdings and its competitors.
Is Clever Leaves Holdings' Research & Development too high?
Clever Leaves Holdings' current Research & Development is $1.14 Mil. Overall, Clever Leaves Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Clever Leaves Holdings' Research & Development compare to CNNC and CLSH?
Clever Leaves Holdings' Research & Development of $1.14 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Clever Leaves Holdings and its competitors. Clever Leaves Holdings's current Research & Development is $1.14 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clever Leaves Holdings stock overvalued right now?
Clever Leaves Holdings (CLVR) has a current Research & Development of $1.14 Mil. The current Research & Development is $1.14 Mil. Clever Leaves Holdings' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Clever Leaves Holdings (CLVR), the current Research & Development is $1.14 Mil as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Clever Leaves Holdings Business Description

Address Bodega 19-B Parque Industrial Tibitoc P.H, Tocancipa, Cundinamarca, Bogota, COL
Clever Leaves Holdings Inc is a producer of pharmaceutical and consumer cannabis brands. The company operates and has investments in Canada, Colombia, Germany, Portugal, and the United States. The company operates in two reportable segments namely, the Cannabinoid segment which is comprised of the company's cultivation, extraction, and commercialization of cannabinoid products; and the Non-Cannabinoid operating segment which generates maximum revenue and is engaged in the business of formulating, manufacturing, marketing, selling, distributing, and otherwise commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements.
12GF Score

Get the complete analysis for CLVR

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price